Boehringer Ingelheim España, S.A. (manufacturing and primary packaging, secondary packaging, quality control and batch release)

The drug is indicated for adults for the short-term symptomatic treatment of acute attacks of rheumatoid arthritis and ankylosing spondylitis in cases where other routes of administration cannot be used.

Dosage form: solution for injection

ATC: M01AC06